symposia-bianco

Innovators in Breast Cancer 2021

con il patrocinio di

Presentazione

Il carcinoma della mammella rappresenta la neoplasia più frequente nella popolazione femminile a livello mondiale.

Negli ultim anni abbiamo assistito all’introduzione di nuove terapie e di farmaci biologici che hanno permesso un netto miglioramento della prognosi delle pazienti sia in fase adiuvante che in fase di malattia metastatica.

Obiettivo del convegno è un incontro tra gli esperti mondiali del carcinoma della mammella per fare il punto sulle principali innovazioni diagnostiche e terapeutiche nell’ottica dell’ottimizzazione e personalizzazione della terapia.

https://www.symposiacongressi.com/wp-content/uploads/2020/07/Symposiafad_access_button-300x180.png

10th September 2021

09.00 Registration & Welcome Coffee

09.20  Welcome to the IBC Meeting 2021

GianCarlo Avanzi, Rector of University of Piemonte Orientale – UPO

Gianfranco Zulian, General Manager,  AOU Maggiore della Carità, Novara

Alessandro Stecco, President, Health Commission Piedmont Regional Council

9.30 Opening of the 3rd IBC Meeting 2021 

Alessandra Gennari, Marco Krengli, Filippo Montemurro

Chairs: Paolo Pronzato, Roberta Siliquini

– COVID-19 and cancer prognosis – David Pinato

– COVID-19: Impact on Breast Cancer – Livia Giordano

Chair Giancarlo Avanzi

Lecture Psycologic Distress during the COVID-19 pandemic  – Gabriella Pravettoni

10.20  How to personalize loco-regional treatment based on the response to neoadjuvant systemic therapy

Chairs: Pierfranco Conte, Marco Krengli,

– The role of systemic therapy and escalation – Valentina Guarneri                      

– Strategies for Targeted Axillary Dissection and Breast Surgery – Germana Lissidini                                                

10.55-11.15  Coffee Break                                                                          

– RT strategy, including indication and volumes (nodes) – Yazid Belkacemi

– RT schedule (technique, including dose and fractionation) – Cynthia Aristei

– RT combination schedules with new drugs – Pierfrancesco Franco

 Discussion

12.30 Management of bone lesions in Breast Cancer

Chairs Alessandra Gennari, Marco Krengli

– Denosumab in early-stage breast cancer  – Michael Gnant

– Treatment of metastatic bone lesions – Daniele Santini

13.00  Lunch                                                                                                 

14.00 Adjuvant therapy in EBC: escalating and de-escalating schedules

Chairs: Fabio Puglisi, Michelino De Laurentiis

– De-escalating and escalating care for early stage ER+/HER2- disease – Fatima Cardoso
– De-escalating and escalating care for early stage HER2+ disease – Pierfranco Conte      

– Guided discussion and vote – Giampaolo Bianchini          

15.00 Pathology Session

Chairs: Renzo Boldorini, Giuseppe Viale,

– Questions for the pathologist by a clinicians – Carmen Criscitiello                                   

– Re-testing of predictive biomarkers on surgical specimens is clinically relevant? Isabella Castellano

– PD-L1 and PI3K: when, where, how? – Caterina Marchiò                                                 

Discussion    

15.50 Molecular Biology

Chairs: Marianna Nuti, Antonio Sica

– Novel RNA-based approaches towards precision medicine in HR+/HER2- breast cancer – Aleix Prat    

– Unraveling Triple-Negative Breast Cancer Tumor Microenvironment Heterogeneity:
towards an Optimized Treatment Approach – Christos Sotiriou                                                   

– Spatial distribution of the immune infiltrate as a putative predictor of recurrence type in triple negative breast cancer – Nina Radosevic                                                          

– Extracellular Vesicles as Signaling Mediators and Disease Biomarkers – Paola Lanuti

Discussion

17.00 Aging,Senescence and Breast Cancer

Chairs: Monica Fornier, Chiara Saggia

– Aging and cell senescence – Luca Magnani

– The Unfit Patient – Laura Biganzoli                                                                       

– The Fit Patient – Etienne Brain                                                                                          

– Anti-senescence compounds: A nutraceutical approach to healthy aging – Massimiliano Bonafè        

Discussion

17.50 End of Friday’s scientific session

11th September 2021

08.30 Breakfast Meeting NO CME
– Focus on Eribulin

Chair: Alessandra Gennari, Filippo Montemurro

Conversation on Eribulin: Clinical Data and Translational Insights –

Javier Cortes, Ornella Garrone

09.00 Triple Negative Breast Cancer: from biology to therapy

Chairs: Massimo Aglietta, Alessandra Gennari

– Lecture: New treatment paradigm “old” targets and game changers – Giuseppe Curigliano

– Germline testing beyond BRCA: Do we need it? – Rachel Wuerlestein

– Fertility issues in BRCA-mutated young patients – Matteo Lambertini

Discussion                                                                                                   

9.50 UPO Alumni Award Women in Academy and Research

Chair: Marco Krengli

Introduction Francesca Boccafoschi, Alessandra Gennari

Recipient Nadia Harbeck,

Awarder GianCarlo Avanzi

Lecture: Academic Research, Education and Patient Care – Nadia Harbeck        

10.30 Coffee Break

10.50 Metastatic Breast Cancer: new targets & old drugs

Chairs: Lucia Del Mastro, Serena Di Cosimo

– CDK 4/6 inhibitors: is there a take home message for daily practice? – Evandro de Azambuja

– CDK 4/6 inhibitors: predictive biomarkers – Grazia Arpino

– New anti-HER2 and older agents: which sequence? – Barbara Pistilli

– Can imaging help tailor HER2-directed therapy? – Carolien Schroder

– Is there still a role for chemotherapy? – Alessandra Fabi

Discussion

12.00 Chairs: Pierluigi Canonico, Giorgio Minotti

Lecture: Regulatory procedures for drug approval in Italy and EU – Armando Genazzani

12.30  14.00 Test genomico per la valutazione del rischio: a che punto siamo?
Genomic test for risk evaluation: where are we now?
Chairs: Mario Airoldi, Massimo Aglietta
Evidenza clinica e dati scientifici
  Clinical evidence and scientific data Fulvia Pedani
Ruolo del paziente nel processo decisionale
Patient advocacy and decision making process –
Rosanna D’Antona
L’esperienza toscana: dai dati scientifici alla pratica clinica
Tuscany experience: from science to clinical practice – Pinuccia Musumeci
– Aspetti normativi e sviluppi futuri
  Regulatory aspects and future developments – Franco Ripa

Tavola rotonda – Round Table: Renzo Boldorini, Isabella Castellano, Giuseppe Curigliano, Lucia Del Mastro, Ornella Garrone, Alessandra Gennari, Filippo Montemurro, Barbara Pistilli, Chiara Saggia, Roberta Siliquini,

Discussion

14.00 Closing of the 3rd IBC Meeting 2021

Lunch

Faculty

Aglietta Massimo Candiolo IT
Airoldi
Mario Torino IT
Aristei Cynthia Perugia IT
Arpino Grazia Napoli IT
Avanzi Giancarlo Novara IT
Belkacémi Yazid Creteil, Paris FR
Bianchini Giampaolo Milano IT
Biganzoli Laura Prato IT
Boccafoschi Francesca Novara IT
Boldorini Renzo Novara IT
Bonafè Massimiliano Bologna IT
Brain Etienne Parigi-Saint Cloud FR
Canonico Pierluigi Novara IT
Cardoso Fatima Lisboa PT
Castellano Isabella Torino IT
Conte Pierfranco Padova IT
Cortes Javier Barcelona ES
Criscitiello Carmen Milano IT
Curigliano Giuseppe Milano IT
D’Antona Rosanna Milano IT
D’Avanzo Francesca Novara IT
De Azambuja Evandro Bruxelles BE
De Laurentiis Michelino Napoli IT
Del Mastro Lucia Genova IT
Di Cosimo Serena Milano IT
Fabi Alessandra Roma IT
Fornier Monica New York US
Franco Pierfrancesco Novara IT
Garrone Ornella Cuneo IT
Genazzani Armando Novara IT
Gennari Alessandra Novara IT
Giordano Livia Torino IT
Gnant Michael Wien AT

 

Guarneri Valentina Padova IT
Harbeck Nadia Munchen DE
Krengli Marco Novara IT
Lambertini Matteo Genova IT
Lanuti Paola Chieti IT
Lissidini Germana  Milano IT
Magnani Luca London UK
Marchiò Caterina Torino IT
Minotti Giorgio Roma IT
Montemurro Filippo Candiolo IT
Musumeci Pinuccia Chianciano IT
Nuti Marianna Roma IT
Pedani Fulvia Torino IT
Pinato David Novara IT
Pistilli Barbara Villejuif, Paris FR
Pravettoni Gabriella Milano IT
Prat Aleix Barcelona ES
Pronzato Paolo Genova IT
Puglisi Fabio Udine IT
Radosevic Nina Clermont Ferrand FR
Ripa Franco Torino IT
Rossi Valentina Novara IT
Saggia Chiara  Novara IT
Santini Daniele Roma IT
Schröder Carolien Groningen NL
Sica Antonio Novara IT
Siliquini Roberta Torino IT
Sotiriou Christos Bruxelles BE
Stecco Alessandro Novara IT
Viale Giuseppe Milano IT
Würstlein Rachel Munchen DE
Zulian Gianfranco Novara IT

Informazioni generali

Conference Chairs
Alessandra Gennari Novara IT
Marco Krengli Novara IT

Course Directors
Alessandra Gennari Novara IT
Marco Krengli Novara IT
Filippo Montemurro Candiolo IT

Scientific Board
Javier Cortes Barcelona ES
Valentina Guarneri Padova IT
Nadia Harbeck Munchen DE

Local Organising Committee

Francesca D’Avanzo Novara IT
Valentina Rossi Novara IT
Chiara Saggia Novara IT

Sede cogressuale

UPO Campus Università del Piemonte Orientale
Aula Magna del Dipartimento di Studi per l’Economia e l’Impresa
via E. Perrone 18
28100 Novara Italy

INFORMATIVA COVID-19
Si ricorda che, in base alle disposizioni di legge a seguito della pandemia Covid-19,
tutti i partecipanti al Congresso (Relatori, Discenti, Staff sponsor, Ospiti, Tecnici, personale addetto alla ristorazione e Segreteria organizzativa, potranno accedere presentando obbligatoriamente al desk della segreteria:
– certificazione di avvenuta vaccinazione (Green Pass)
oppure
– certificazione di avvenuta guarigione
oppure
– certificazione di test antigenico rapido o molecolare NEGATIVO
Sarà  comunque, all’ingresso, sempre eseguita la verifica della temperatura (non superiore a 37,5°C), con termoscanner
Sarà sempre obbligatorio l’uso della mascherina

Informazioni ECM

  • ID evento: 486-324494

  • N° crediti: 10

  • Professione: Medico chirurgo

  • Disciplina:

  • Oncologia

    Medicina interna

    Ematologia

    Radioterapia

    Chirurgia generale

    Chirurgia plastica e ricostruttiva

    Ginecologia e ostetricia

    Anatomia patologica

    Radiodiagnostica

  • Obiettivo Formativo: Linee guida - protocolli - procedure




ISCRIZIONE

Quota di iscrizione euro 366,00 Iva 22% compresa

Il corso è stato accreditato per 100 persone

symposia-bianco
symposia@symposiacongressi.com

Symposia Organizzazione Congressi Srl
Piazza Campetto 2/8 – 16123 Genova

Tel. 010 255146 r.a. – Fax 010 2770565
symposia@symposiacongressi.com

P.IVA 03849570100

PHP Code Snippets Powered By : XYZScripts.com